NanoString Technologies, Inc. (NASDAQ:NSTG) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET

Company Participants

Doug Farrell – Investor Relations

Brad Gray – President and Chief Executive Officer

Tom Bailey – Chief Financial Officer

Conference Call Participants

Kyle Boucher – Cowen

Dan Arias – Stifel

Kyle Mikson – Canaccord

John Sourbeer – UBS

Operator

Good afternoon. Thank you for attending today's NanoString Fourth Quarter and Fiscal Year 2022 Operating Results Call. My name is Porum and I’ll be your moderator for today’s call. All lines will remain muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions]

It is now pleasure to pass the conference over to our host Doug Farrell, Investor Relations of NanoString. Mr. Farrell, please go ahead.

Doug Farrell

Thank you, operator, and thanks for joining us today. On the call with me today is Brad Gray, our President and CEO; as well as CFO, Tom Bailey. Earlier today, we released our financial results for the fourth quarter and fiscal year ended December 31, 2022. During this call, we may make statements that are forward-looking, including statements about financial and operating projections, future business growth, trends and related factors, expectations regarding future operating results, future cash flows, current and future instrument orders, prospects for expanding and penetrating our addressable markets, and our strategic focus and objectives, as well as the development status and anticipated success of recently product offerings and the impact of macroeconomic factors.

Forward-looking statements are subject to risks and uncertainties, including those described in our SEC filings. Our results may differ materially from those projected, and we undertake no obligation to update any forward-looking statements. Later in the call, Tom will be discussing our financial results and guidance for 2023. We have prepared as a supplement the GAAP financial measures, selected non-GAAP adjusted measures, the calculation of which are described in detail on press release. Throughout this call, all financial measures will be GAAP unless otherwise noted. You can also find reconciliations of GAAP to non-GAAP measures, as well as the description, limitations, and rationale for using each such measure in this afternoon's press release.

To aid the analysts and investors in building their models, we have posted exhibits under the financial information tab of our Investor Relations home page that include a presentation of our non-GAAP or adjusted measures and selected other financial data. I'd like to remind everyone that we'll be participating in the Cowen Healthcare Conference in March next week in addition to our fireside corporate discussion Brad will also be participating in a panel focused on AI based genomics and drug discovery on Tuesday afternoon that will include participants from NVIDIA and Generative Medicine. We look forward to having the opportunity to speak with many of you then.